History | Upadacitinib for treating severe rheumatoid arthritis | Guidance | NICE

History

Documents created during the development process.

Declaration of interests

Register of interests (PDF 270 KB)

Published:

29 October 2021

Expected publication

Equality Impact Assessment (Guidance development) (PDF 136 KB)

Published:

09 December 2020

Final draft guidance

Final draft guidance
Final appraisal document (PDF 255 KB)

Published:

06 November 2020
Committee papers (PDF 1.59 MB)

Published:

06 November 2020
Public committee slides (PDF 1.11 MB)

Published:

06 November 2020

Draft guidance

Draft guidance
Appraisal consultation document (PDF version) (PDF 337 KB)

Published:

31 January 2020
Appraisal consultation document (online commenting)
Committee papers (PDF 6.27 MB)

Published:

31 January 2020
Public committee slides (PDF 1.26 MB)

Published:

31 January 2020

Invitation to participate

Final scope (PDF 205 KB)

Published:

01 May 2019
NICE's response to comments on the draft scope and provisional stakeholder list (PDF 253 KB)

Published:

01 May 2019
Equality impact assessment (Scoping) (PDF 123 KB)

Published:

01 May 2019
Final stakeholder list (PDF 202 KB)

Published:

01 May 2019

Consultation on suggested remit, draft scope and provisional matrix of consultees and commentators

Draft scope pre referral (PDF 350 KB)

Published:

01 October 2018
Draft matrix pre referral (PDF 294 KB)

Published:

01 October 2018